title: Biological mesh for abdominal wall hernia synthetic mesh multidrug-resistant Pseudomonas aeruginosa infection: report of a case.
abstract: The use of biological mesh for the treatment of synthetic mesh-related infections in patients who undergo ventral hernia repair has been considered over the past few years. Removal of the infected synthetic mesh, which may be required in such cases, can result in recurring herniation. Biological implants have thus been recently used for the reconstruction of the existing defect. We herein present the case of a patient who developed multidrug-resistant Pseudomonas aeruginosa synthetic mesh infection following hernia repair, which was managed by the removal of the material and the application of a biological mesh in the contaminated area.
authors.affiliation: Alfa Institute of Biomedical Sciences (AIBS), 9 Neapoleos Street, 151 23, Marousi, Greece.
authors.forename: George
authors.initials: G
authors.lastname: Peppas
authors.forename: Marinos C
authors.initials: MC
authors.lastname: Makris
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Falagas
mesh_terms: D001705:Bioprosthesis; D020878:Device Removal; D024901:Drug Resistance, Multiple, Bacterial; D046449:Hernia, Abdominal / Q000601:surgery; D006801:Humans; D008297:Male; D008875:Middle Aged; D011126:Polypropylenes; D016459:Prosthesis-Related Infections / Q000188:drug therapy / Q000382:microbiology*; D011552:Pseudomonas Infections / Q000188:drug therapy* / Q000209:etiology; D011550:Pseudomonas aeruginosa / Q000187:drug effects*; D012086:Reoperation; D013526:Surgical Mesh / Q000009:adverse effects
chemical_list: D011126:Polypropylenes